Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  R RESPIRATORY SYSTEM
    R01 NASAL PREPARATIONS
      R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
        R01AA Sympathomimetics, plain
          R01AA08 Naphazoline [DG:DG01032]
            D01021  Naphazoline nitrate (JP17) <JP>
        R01AB Sympathomimetics, combinations excl. corticosteroids
          R01AB02 Naphazoline [DG:DG01032]
            D01021  Naphazoline nitrate (JP17) <JP>
  S SENSORY ORGANS
    S01 OPHTHALMOLOGICALS
      S01G DECONGESTANTS AND ANTIALLERGICS
        S01GA Sympathomimetics used as decongestants
          S01GA01 Naphazoline [DG:DG01032]
            D01021  Naphazoline nitrate (JP17) <JP>

Therapeutic category of drugs in Japan [BR:br08301]
  1  Agents affecting nervous system and sensory organs
    13  Agents affecting sensory organs
      131  Ophthalmic agents
        1316  Ophthalmic local vasoconstrictors
          D01021  Naphazoline nitrate (JP17)	R01AA08 R01AB02 S01GA01
      132  Otic and nasal agents
        1324  Otolaryngologic vasoconstrictors
          D01021  Naphazoline nitrate (JP17)	R01AA08 R01AB02 S01GA01

Risk category of Japanese OTC drugs [BR:br08312]
  Second-class OTC drugs
    Inorganic and organic chemicals
      Naphazoline
        D01021  Naphazoline nitrate (JP17)

Target-based classification of drugs [BR:br08310]
  G Protein-coupled receptors
    Rhodopsin family
      Adrenaline
        ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
          D01021  Naphazoline nitrate (JP17) <JP>

Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
  Chemicals
    D01021  Naphazoline nitrate

[ BRITE | KEGG2 | KEGG ]